BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Jersey's wellbeing score is below UK and France - 2'No Kings' protests recap: More than 8 million turned out across all 50 states, organizers say
- 3They died 'doing what they loved': The stories of workers in their 80s who died on the job
- 4Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- 5Factbox-Artemis II crew includes first woman, Black astronaut and Canadian ever flown to moon
- Jubilant FoodWorks to scrap Dunkin’ franchise arrangement in India
- David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.
- He suddenly couldn't speak in space. NASA astronaut says his medical scare remains a mystery
- Meet Beef the bulldog, who takes slow walks with his 78-year-old friend
- Iran, Hezbollah fire rockets at Israel during Passover celebrations
- Ober Gabelhorn glacier reveals remains of man missing for over three decades
- The Fate of Gaming: 5 Energizing Advancements Not too far off
- Tributes pour in for James Ransone, 'The Wire' actor who died at 46
- 5 Home EV Chargers for Proficient and Solid Charging
